Patent details

Basic Information

Publication number:

EP3639856

PCT Application Number:

KR2018006954

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188626147

PCT Publication Number:

WO2019066199

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

LONG-ACTING PALMITIC ACID-CONJUGATED GNRH DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

French Title of Invention:

DÉRIVÉ DE GNRH CONJUGUÉ À DE L'ACIDE PALMITIQUE À ACTION PROLONGÉE ET COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI

German Title of Invention:

LANGWIRKENDES PALMITINSÄUREKONJUGIERTES GNRH-DERIVAT UND DIESES ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

20/06/2018

Grant date:

03/08/2022

EP Publication Date:

22/04/2020

PCT Publication Date:

04/04/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/08/2022

EP B1 Publication Date:

03/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/06/2023

Expiration date:

20/06/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/07/2022

 

 

Name:

Novel Pharma Inc.

Address:

1901, 36, Teheran-ro 87-gil, Gangnam-gu Seoul 06164, Korea (Republic) (KR)

Inventor

Name:

JIN, Dong Kyu

Address:

Korea (Republic) (KR)

Priority

Priority Number:

20170125291

Priority Date:

27/09/2017

Priority Country:

Korea (Republic) (KR)

Classification

IPC classification:

A61K 47/54; C07K 7/23; A61P 35/00; A61K 38/00;

Publication

European Patent Bulletin

Issue number:

202231

Publication date:

03/08/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages